This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.64% per year. These returns cover a period from January 1, 1988 through August 4, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
CIT Group (CIT) Looks Good: Stock Adds 6.1% in Session
by Zacks Equity Research
CIT Group (CIT) saw a big move last session, as its shares jumped more than 6% on the day, amid huge volumes.
American Express (AXP) Q1 Earnings Beat, Revenues Miss
by Zacks Equity Research
American Express' (AXP) Q1 results benefit from billings and loan growth, partly offset by increase in expenses.
SYF vs. HLI: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
SYF vs. HLI: Which Stock Is the Better Value Option?
Houlihan Lokey (HLI) Q3 Earnings and Revenues Top Estimates
by Zacks Equity Research
Houlihan Lokey (HLI) delivered earnings and revenue surprises of 14.93% and 18.82%, respectively, for the quarter ended December 2018. Do the numbers hold clues to what lies ahead for the stock?
HLI vs. MCO: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
HLI vs. MCO: Which Stock Is the Better Value Option?
Houlihan Lokey (HLI) Surpasses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Houlihan Lokey (HLI) delivered earnings and revenue surprises of 12.90% and 14.73%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
Houlihan Lokey (HLI) Q2 Earnings Preview: What to Watch Ahead of the Release
by Zacks Equity Research
Houlihan Lokey (HLI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Moving Average Crossover Alert: Houlihan Lokey (HLI)
by Zacks Equity Research
Houlihan Lokey, Inc. (HLI) could be a stock to avoid from a technical perspective
The Zacks Analyst Blog Highlights: CME Group, Discover Financial Services, Leucadia National and Houlihan Lokey
by Zacks Equity Research
The Zacks Analyst Blog Highlights: CME Group, Discover Financial Services, Leucadia National and Houlihan Lokey
Finance Stocks Jul 26 Q2 Earnings Roster: CME, DFS, JEF, HLI
by Zacks Equity Research
Rising interest rates and lowered tax incidence should drive the finance sector's second-quarter performance.
Zacks.com highlights: HollyFrontier, Amedisys, MGM Growth Properties, Louisiana-Pacific and Houlihan Lokey
by Zacks Equity Research
Zacks.com highlights: HollyFrontier, Amedisys, MGM Growth Properties, Louisiana-Pacific and Houlihan Lokey
Bet on These 5 Low Leverage Stocks for Safe Returns
by Zacks Equity Research
As we are off to a strong start in the Q2 earnings season, blindly pursuing high earnings yielding stocks might drain all your money before you know, if the stock bears a high debt-to-equity ratio.
5 Solid Reasons to Retain PRA Group (PRAA) in Your Portfolio
by Zacks Equity Research
Riding high on five factors, PRA Group (PRAA) holds great potential to reap hefty returns for investors.
Why MoneyGram's (MGI) Stock Fell More Than 40% in a Year?
by Zacks Equity Research
MoneyGram (MGI) seems to suffer from pricing woes, economic instability in markets, high compliance costs and increased competition.
Zacks.com highlights: SKECHERS USA, US Foods Holding, Dine Brands Global, Houlihan Lokey and Global Brass and Copper Holdings
by Zacks Equity Research
Zacks.com highlights: SKECHERS USA, US Foods Holding, Dine Brands Global, Houlihan Lokey and Global Brass and Copper Holdings
Don't Fret Over Market Volatility: Focus on 5 Low-Beta Stocks
by Zacks Equity Research
We have developed an investment strategy that clearly shows that stocks with lesser risk can also generate impressive returns.
CIT Group's (CIT) Outlook Upgraded to Positive by Moody's
by Zacks Equity Research
CIT Group's (CIT) strong fundamentals and efforts to improve efficiency will go a long way in supporting profitability. These are the primary reasons for an outlook upgrade by Moody's.
Why Earnings Season Could Be Great for Houlihan Lokey (HLI)
by Zacks Equity Research
Houlihan Lokey (HLI) is seeing favorable earnings estimate revision activity as of late, which is generally a precursor to an earnings beat.
Will Top-Line Growth Aid Total System (TSS) Earnings in Q4?
by Zacks Equity Research
Total Systems' (TSS) earnings are likely to be aided by revenue growth across all its segments.
New Strong Buy Stocks for January 15th
by Tirthankar Chakraborty
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Monday
MoneyGram (MGI) Boosts Money Transfer in China Via PSBC
by Zacks Equity Research
The latest money transfer services by MoneyGram (MGI) via Postal Savings Bank of China's mobile app are likely to expand its reach in China.
MoneyGram (MGI) Q3 Earnings Beat, Revenues Miss Estimates
by Zacks Equity Research
MoneyGram's (MGI) third-quarter revenues suffered from macroeconomic softness in some of its markets, a volatile immigration environment and other factors.
3 Reasons to Add Moody's (MCO) Stock to Your Portfolio Now
by Zacks Equity Research
Moody's is well positioned for growth on the back of its diverse revenue base and synergies from acquisitions. Here are the reasons that it is expected to be a solid pick now.
Blackhawk Network Holdings (HAWK) In Focus: Stock Jumps 8.2%
by Zacks Equity Research
Blackhawk Network Holdings, Inc. (HAWK) moved big last session, as its shares jumped a little over 8% on the day.
CIT Group (CIT) to Divest Stake in TC-CIT Joint Ventures
by Zacks Equity Research
In sync with its decision to exit the commercial aircraft leasing business, CIT Group Inc. (CIT) announced to sell 30% stake in the joint ventures with Tokyo Century Corporation. The deal is expected to be completed by Mar 31.